Table of Contents CME Group enables clients to trade futures, options, cash and over-the-counter (OTC) products, optimize portfolios and analyze data - empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group provides primary price discovery and referential pricing information through its market data in a variety of formats, including real-time, historical and derived data for customers in both listed and cash products. CME Group also offers industry-leading research and analytics tools to provide customers with market education resources. In addition, it operates one of the world's leading central counterparty clearing providers. Our principal executive offices are located at 20 South Wacker Drive, Chicago, Illinois 60606, our telephone number is 312-930-1000 and our website is cmegroup.com.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 6.5B | 6.5B | 6.1B | 5.6B | 5.0B | 4.7B |
| Net Income | 4.0B | 4.0B | 3.5B | 3.2B | 2.7B | 2.6B |
| EPS | $11.16 | $11.16 | $9.67 | $8.86 | $7.40 | $7.29 |
| Free Cash Flow | 4.2B | 4.2B | 3.6B | 3.4B | 3.0B | 2.3B |
| ROIC | 11.6% | 13.1% | 11.9% | 10.6% | 8.8% | 8.7% |
| Gross Margin | 86.1% | 86.1% | 86.1% | 85.1% | 85.0% | 82.2% |
| Debt/Equity | 0.12 | 0.12 | 0.13 | 0.13 | 0.13 | 0.13 |
| Dividends/Share | $10.92 | $10.92 | $10.40 | $9.65 | $8.50 | $5.90 |
| Operating Income | 4.2B | 4.2B | 3.9B | 3.4B | 3.0B | 2.6B |
| Operating Margin | 64.9% | 64.9% | 64.1% | 61.6% | 60.1% | 56.4% |
| ROE | 14.0% | 14.6% | 13.1% | 11.9% | 9.9% | 9.6% |
| Shares Outstanding | 360M | 360M | 360M | 360M | 359M | 359M |
CME GROUP INC. passes 6 of 9 quality checks, suggesting mixed fundamentals.
CME GROUP INC. trades at 26.9x trailing earnings, compared to its 15-year median P/E of 23.7x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 25.8x vs a median of 21.5x. The company's 5-year average ROIC is 10.6% with a gross margin of 84.9%. Total shareholder yield (dividends) is 3.6%. At current prices, the estimated annualized return to fair value is +8.7%.
CME GROUP INC. (CME) has a current P/E ratio of 26.9, compared to its historical median P/E of 23.7. The stock is currently considered Fair based on its historical valuation range.
CME GROUP INC. (CME) has a 5-year average return on invested capital (ROIC) of 10.6%. This indicates solid capital allocation.
CME GROUP INC. (CME) has a market capitalization of $108.3B. It is classified as a large-cap stock.
Yes, CME GROUP INC. (CME) pays a dividend with a trailing twelve-month yield of 3.63%.
Based on historical P/E analysis, CME GROUP INC. (CME) appears fair. The current P/E of 26.9 is 14% above its historical median of 23.7. The estimated fair value CAGR (P/E method) is 9.1%.
CME GROUP INC. (CME) operates in the Security & Commodity Brokers, Dealers, Exchanges & Services industry, within the Financials sector.
CME GROUP INC. (CME) reported annual revenue of $6.5 billion in its most recent fiscal year, based on SEC EDGAR filings.
CME GROUP INC. (CME) has a net profit margin of 61.7%. This is a strong margin indicating high profitability.
CME GROUP INC. (CME) generated $4.2 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
CME GROUP INC. (CME) has a debt-to-equity ratio of 0.12. This indicates a conservatively financed balance sheet.
CME GROUP INC. (CME) reported earnings per share (EPS) of $11.16 in its most recent fiscal year.
CME GROUP INC. (CME) has a return on equity (ROE) of 14.6%. This indicates moderate shareholder returns.
CME GROUP INC. (CME) has a 5-year average gross margin of 84.9%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 19 years of financial data for CME GROUP INC. (CME), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
CME GROUP INC. (CME) has a book value per share of $79.73, based on its most recent annual SEC filing.